Impact of autologous hematopoetic stem cell transplantation on the quality of life of patients with multiple sclerosis.

Objective: To evaluate the impact of autologous hematopoetic stem cell transplantation (autoHSCT) in the health related quality of life (HRQL) in patients with multiple sclerosis.

Method: The sample consisted of 34 patients, over 18 years old, treated at a University Hospital in the state of São Paulo, Brazil. For data collection MOS SF-36 and EDSS scales were applied at three time points: admission of the patient, hospital discharge and 1 year posttransplantation.

Quality of life of patients with autoimmune diseases submitted to bone marrow transplantation: a longitudinal study.

This study aimed to assess the quality of life of patients with autoimmune diseases (AID) submitted to Bone Marrow Transplantation (BMT) at two different moments: when the patient is admitted at the hospital and at the moment of hospital discharge (30 days after the transplantation). Patients who attended the BMT unit, were older than 18 years, with conditions and availability to voluntarily collaborate to the study were selected. Data were collected through a semi-structured interview and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36).